Human genetic factors related to susceptibility to mild malaria in Gabon

Genes and Immunity

Volumn 1, Issue 7, 2000, Pages 435-441

  Migot Nabias, F ^b   Mombo, L E ^f   Luty, A J F ^c   Dubois, B ^a   Nabias, R ^f   Bisseye, C ^f   Millet, P ^d   Lu, C Y ^e   Deloron, P ^f  

^a BICHAT HOSPITAL   (France)

^b CENTRE INTERNATIONAL DE RECHERCHES MÉDICALES DE FRANCEVILLE   (Gabon)

^c Institut fur Tropenmedizin   (Germany)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f NONE

Author keywords

Gabon; Genetic polymorphisms; Immunity; Malaria; Plasmodium falciparum

Indexed keywords

PLASMODIUM FALCIPARUM;

HEMOGLOBIN; PARASITE ANTIGEN; PRIMER DNA; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BLOOD; BLOOD GROUP ABO SYSTEM; CHILD; COHORT ANALYSIS; FEMALE; GABON; GENETICS; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; IMMUNOLOGY; MALARIA FALCIPARUM; MALE; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; RISK FACTOR; SICKLE CELL TRAIT;

ABO BLOOD-GROUP SYSTEM; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; BASE SEQUENCE; CHILD; COHORT STUDIES; DNA PRIMERS; FEMALE; GABON; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOGLOBINS; HUMANS; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; RISK FACTORS; SICKLE CELL TRAIT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034304855     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363703     Document Type: Article

References (49)

1. Wilkinson RJ, Pasvol G. Host resistance to malaria runs into swampy water. Trends Microbiol 1997; 5: 213-215.
2. Hill AVS. The immunogenetics of human infectious diseases. Annu Rev Immunol 1998; 16: 593-617.
3. Miller LH. Impact of malaria on genetic polymorphism and genetic diseases in Africans and African Americans. Proc Natl Acad Sci USA 1994; 91: 2415-2419.
4. Hill AVS. Malaria resistance genes: a natural selection. Trans R Soc Trop Med Hyg 1992; 86: 225-226 and 232.
5. Lell B, May J, Schmidt-Ott RJ et al. The role of red blood cell polymorphisms in resistance and susceptibility to malaria. Clin Infect Dis 1999; 28: 794-799.
6. Domarle O, Migot-Nabias F, Mvoukani JL et al. Factors influencing resistance to re-infection with Plasmodium falciparum. Am J Trop Med Hyg 1999; 61: 926-931.
7. Hill AVS, Allsopp CEM, Kwiatkowski D et al. Common West African HLA antigens are associated with protection from severe malaria. Nature 1991; 352: 595-600.
8. Bienzle U, Ayeni O, Lucas AO, Luzzatto L. Glucose-6-phosphate dehydrogenase and malaria. Greater resistance of females heterozygous for enzyme deficiency and of males with non-deficient variant. Lancet 1972; I: 107-110.
9. Martin SK, Miller LH, Ailing D et al. Severe malaria and glucose-6-phosphate-dehydrogenase deficiency: a reappraisal of the malaria/G-6-PD hypothesis. Lancet 1979; 1: 524-526.
10. Ruwende C, Khoo SC, Snow RW et al. Natural selection of hemi and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 1995; 376: 246-249.
11. Knight JC, Udalova I, Hill AVS et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999; 22: 145-150.
12. McGuire W, Knight JC, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis 1999; 179: 287-290.
13. Wattavidanage J, Carter R, Perera KLRL et al. TNFα*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans. Clin Exp Immunol 1999; 115: 350-355.
14. Deloron P, Ringwald P, Luty AJF et al. Relationships between malaria prevalence and malaria-related morbidity in school-children from two villages in Central Africa. Am J Trop Med Hyg 1999; 61: 99-102.
15. Migot-Nabias F, Luty AJF, Ringwald P et al. Immune responses against P. falciparum asexual blood stage antigens and disease susceptibility in Gabonese and Cameroonian children. Am J Trop Med Hyg 1999; 61: 488-494.
16. Migot-Nabias F, Deloron P, Ringwald P et al. Immune response to P. falciparum liver stage antigen-1 : geographical variations within Central Africa and their relationship with protection from clinical malaria. Trans R Soc Trop Med Hyg 2000; 94: in press.
17. Fisher PR, Boone P. Short report: severe malaria associated with blood group. Am J Trop Med Hyg 1998; 58: 122-123.
18. Udomsangpetch R, Todd J, Carlson J, Greenwood BM. The effects of hemoglobin genotype and ABO blood group on the formation of rosettes by Plasmodium falciparum-infected red blood cells. Am J Trop Med Hyg 1993; 48: 149-153.
19. Carlson J, Wahlgren M. Plasmodium falciparum erythrocyte rosetting is mediated by promiscuous lectin-like interactions. J Exp Med 1992; 176: 1311-1317.
20. Akinboye DO, Ogunrinade AF. Malaria and loaisis among blood donors at Ibadan, Nigeria. Trans R Soc Trop Med Hyg 1987; 81: 398-399.
21. Guggenmoos-Holzmann I, Bienzle U, Luzzatto L. Plasmodium falciparum malaria and human red cells. II. Red cell genetic traits and resistance against malaria. Int J Epidemiol 1981; 10: 16-22.
22. Le Hesran JY, Pesonne I, Personne P et al. Longitudinal study of Plasmodium falciparum infection and immune reponses in infants with or without the sickle cell trait. Int J Epidemiol 1999; 28: 793-798.
23. Marsh K, Otoo L, Hayes RJ, Carson DC, Greenwood BM. Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg 1989; 83: 293-303.
24. Cot M, Abel L, Roisin A et al. Risk factors of malaria infection during pregnancy in Burkina Faso: suggestion of a genetic influence. Am J Trop Med Hyg 1993; 48: 358-364.
25. Rihet P, Abel L, Traoré Y, Traoré-Leroux T, Aucan C, Fumoux F. Human malaria: segregation analysis of blood infection levels in a suburban area and a rural area in Burkina Faso. Genetic Epidemiol 1998; 15: 435-450.
26. Ringelhann B, Hathorn MK, July P, Grant F, Parniczky G. A new look at the protection of hemoglobin AS and AC genotypes against Plasmodium falciparum infection: a census tract approach. Am J Hum Genet 1976; 28: 270-279.
27. Allen SJ, Bennett S, Riley EM et al. Morbidity from malaria and immune responses to defined Plasmodium falciparum antigens in children with sickle cell trait in The Gambia. Trans R Soc Trop Med Hyg 1992; 86: 494-498.
28. Ruwende C, Hill A. Glucose-6-phosphate dehydrogenase deficiency and malaria. J Mol Med 1998; 76: 581-588.
29. Bienzle U, Guggenmoos-Holzmann I, Luzzatto L. Malaria and erythrocyte glucose-6-phosphate dehydrogenase variants in West Africa. Am J Trop Med Hyg 1979; 28: 619-621.
30. Martin SK. The malaria/G6PD hypothesis revisited. Parasitol Today 1994; 10: 251-252.
31. Beutler E, Yeh M, Fairbanks VF. The normal human female as a mosaic of X chromosome activity. Studies using the gene for G-6-PD deficiency as a marker. Proc Natl Acad Sci USA 1962; 48: 9-13.
32. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-511.
33. Boussiotis VA, Nadler LM, Strominger JL, Goldfeld AE. Tumor necrosis factor a is an autocrine growth factor for normal human B cells. Proc Natl Acad Sci USA 1994; 91: 7007-7011.
34. Goldfeld AE, Tsai EY. TNF-α and genetic susceptibility to parasitic disease. Exp Parasitol 1996; 84: 300-303.
35. Le Hir M, Bluethmann H, Kosco-Vilbois MH et al. Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J Exp Med 1996; 183: 2367-2372.
36. Kun JFJ, Mordmüller B, Lell B, Lehman LG, Luckner D, Kremsner PG. Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 1998; 351: 265-266.
37. Burgner D, Xu W, Rockett K et al. Inducible nitric oxide synthase polymorphism and fatal cerebral malaria. Lancet 1998; 352: 1193-1194.
38. Clark IA, Rockett KA, Cowden WB. Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet 1992; 340: 894-896.
39. Chiwakata CB, Hemmer CJ, Dietrich M. High levels of inducible nitric oxide synthase mRNA are associated with increased monocyte counts in blood and have a beneficial role in Plasmodium falciparum malaria. Infect Immun 2000; 68: 394-399.
40. Anstey NM, Weinberg JB, Hassanali MY et al. Nitric oxide in Tanzanian children with malaria : inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med 1996; 184: 557-567.
41. Epstein J, Eichbaum Q, Sheriff S, Ezekowitz RAB. The collectins in innate immunity. Curr Opin Immunol 1996; 8: 29-35.
42. Turner MW. Mannose-binding lectin : the pluripotent molecule of the innate immune system. Immunol Today 1996; 17: 532-540.
43. Luty AJF, Kun JF, Kremsner PG. Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria. J Infect Dis 1998; 178: 1221-1224.
44. Bellamy R, Ruwende C, Mcadam KPWJ et al. Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans. Q J Med 1998; 91: 13-18.
45. Ntoumi F, Mercereau-Puijalon O, Ossari S et al. Plasmodium falciparum: sickle-cell trait is associated with higher prevalence of multiple infections in Gabonese children with asymptomatic infections. Exp Parasitol 1997; 87: 39-46.
46. Ntoumi F, Rogier C, Dieye A, Trape JF, Millet P, Mercereau-Puijalon O. Imbalanced distribution of Plasmodium falciparum MSP-1 genotypes related to sickle-cell trait. Mol Med 1997; 3: 581-592.
47. Mount DL, Nahlen BL, Patchen LC, Churchill FC. Adaptations of the Saker-Solomons test : simple, reliable colorimetric field assays for chloroquine and its metabolites in urine. Bull WHO 1989; 67: 295-300.
48. Saiki RK, Scharf S, Faloona F et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350-1354.
49. Neonato MG, Lu CY, Guilloud-Bataille M et al. Genetic polymorphism of the mannose-binding protein gene in children with sickle cell disease: identification of three new variant alleles and relationship to infections. Eur J Hum Genet 1999; 7: 679-686.